A dual-target GUCY2C-CD3 binder improves T-cell synapse formation and tumor cell killing in gastrointestinal cancers.
Deleting 1-18 C-terminal residues from OaPAC boosts photoactivation efficiency, enabling lower light use and reducing photodamage risk.